member	Other
significant_tumor_growth_reduction	Disease
cell_cycle	Other
model	Other
model	Other
EgKI-1	Other
EgKI-1	Other
EgKI-1_treatment	Other
model	Other
recombinant_EgKI-1	Other
recombinant_EgKI-1	Other
in_model	Other
EgKI-1	Other
member	Other
member	Other
EgKI-1	Other
EgKI-1_treatment	Other
model	Other
cell_cycle	Other
EgKI-1_treatment	Other
member	Other
model	Other
member	Other
member	Other
co-treatment	Other
cell_growth	Other
cell_growth	Other
cell_cycle	Other
cell_cycle	Other
combined_treatment	Other
investigated	Other
combined_treatment	Other
combined_treatment	Other
treatment	Other
combined_treatment	Other
cells	Other
investigated	Other
cell_proliferation	Other
naringenin	Chemical
cell_proliferation	Other
investigated	Other
Breast_cancer	Disease
investigated	Other
naringenin_treatment_group	Chemical
treatment	Other
investigated	Other
combined_treatment	Other
naringenin	Chemical
cell_proliferation	Other
co-treatment	Other
treatment	Other
naringenin	Chemical
treatment	Other
cell_migration	Other
naringenin	Chemical
treatment	Other
cell_proliferation	Other
combined_treatment	Other
purpose	Other
3D_phantom	Other
random_distribution	Other
modality	Other
breast_lesion_model	Other
tumor_models	Disease
characteristics	Other
3D_phantom	Other
uniform_distribution	Other
random_distribution	Other
time-enhancement_curves	Other
3D_static_phantom	Other
perfusion	Other
tumor_models	Disease
3D_phantom	Other
distribution	Other
tumor_models	Disease
modality	Other
typical_4D_phantom	Other
distribution	Other
uniform_random_distribution	Other
uniform_random_distribution	Other
proposed_digital_phantom	Other
typical_4D	Other
modality	Other
modality	Other
3D_static_phantom	Other
arterial_sources	Other
detection_diagnosis	Other
distribution	Other
uniform_distribution	Other
Results	Other
proposed_digital_phantom	Other
random_distribution	Other
distribution	Other
curves	Other
distribution	Other
modality	Other
modality	Other
corresponding_curves	Other
proposed_phantom	Other
uniform_distribution	Other
corresponding_time-enhancement_curves	Other
modality	Other
phantom	Other
random_distribution	Other
exponential	Other
modality	Other
tumor_models	Disease
digital_phantom	Other
modality	Other
curves	Other
activities	Other
percent_cytotoxicity	Disease
aqueous_Orthosiphon_pallidus_extract	Other
objective	Other
Orthosiphon_pallidus_extract	Other
percent_cytotoxicity	Disease
Orthosiphon_pallidus_extract	Other
activities	Other
anticancer_activities	Other
anticancer_activities	Other
percent_cytotoxicity	Disease
Orthosiphon_pallidus_extract	Other
percent_cytotoxicity	Disease
Orthosiphon_pallidus_extract	Other
percent_cytotoxicity	Disease
objective	Other
percent_cytotoxicity	Disease
objective	Other
activities	Other
total	Other
potent_activity	Other
objective	Other
percent_cytotoxicity	Disease
Orthosiphon_pallidus_extract	Other
percent_cytotoxicity	Disease
percent_cytotoxicity	Disease
Orthosiphon_pallidus_extract	Other
retrospective_study	Other
retrospective_study	Other
196_patients	Species
serious_damage	Other
retrospective_study	Other
retrospective_study	Other
patients	Species
anthracycline-based_adjuvant_therapies	Other
serious_damage	Other
study	Other
women	Species
damage	Other
damage	Other
clinicians	Other
patients	Species
patients	Species
Most_patients	Species
clinicians	Other
analysis	Other
Patient_self-reports	Species
Most_patients	Species
Female_patients	Species
patients	Species
T-PAT_participants	Disease	Species
effects	Other
patients	Species
findings	Other
compound	Other
findings	Other
repeated_preparations	Other
compound	Other
compound	Other
Targeting_breast_CSCs	Other
repeated_preparations	Other
aldehyde_dehydrogenase	Chemical
chromatographic_preparations	Other
compound	Other
repeated_chromatographic_preparations	Other
Targeting_breast_CSCs	Other
findings	Other
chromatographic_preparations	Other
preparations	Other
preparations	Other
repeated_chromatographic_preparations	Other
compound	Other
Targeting_breast_CSCs	Other
Patients	Species
G1	Other
G1	Other
patients	Species
Hypofractionated_VMAT-SIB	Other
outcomes	Other
cosmetic_outcomes	Other
VMAT-SIB	Other
outcomes	Other
cosmetic_outcomes	Other
patients	Species
Cosmetic_outcomes	Other
outcomes	Other
Our_data	Other
G1	Other
outcomes	Other
Cosmetic_outcomes	Other
Hypofractionated_VMAT-SIB	Other
patients	Species
Hypofractionated_VMAT-SIB	Other
outcomes	Other
Patients	Species
Hypofractionated_VMAT-SIB	Other
Patients	Species
patients	Species
patients	Species
cosmetic_outcomes	Other
patients	Species
assays	Other
Higher_expression	Other
clinicopathological_parameters	Other
patients	Species
clinicopathological_parameters	Other
effect	Other
Enhanced_understanding	Other
Higher_expression	Other
several_parameters	Other
several_clinicopathological_parameters	Other
Higher_expression	Other
assays	Other
late_recurrences	Other
intervention	Other
several_parameters	Other
several_clinicopathological_parameters	Other
expression	Other
expression	Other
expression	Other
late_recurrence_risk	Other
recurrence_selection_tools	Other
showing	Other
late_recurrence_selection_tools	Other
parameters	Other
effect	Other
parameters	Other
intervention	Other
predicting	Other
Long-term_intervention	Other
Extended_endocrine_therapy	Other
recurrence_selection_tools	Other
multigene_assays	Other
intervention	Other
Enhanced_understanding	Other
showing	Other
showing	Other
Higher_expression	Other
intervention	Other
diagnosis	Other
Long-term_intervention	Other
Extended_endocrine_therapy	Other
Extended_therapy	Other
Long-term_intervention	Other
late_recurrence_selection_tools	Other
Enrichment_Analysis	Other
understanding	Other
Higher_expression	Other
expression	Other
late_recurrences	Other
Long-term_intervention	Other
Long-term_intervention	Other
intervention	Other
intervention	Other
expression	Other
Long-term_intervention	Other
Long-term_intervention	Other
recurrence_selection_tools	Other
expression	Other
Higher_expression	Other
therapy	Other
estrogen_receptor	Chemical
Extended_therapy	Other
patients	Species
multigene_assays	Other
showing	Other
therapy	Other
late_recurrence_selection_tools	Other
Ongoing_research	Other
important_growth_pathway	Other
data	Other
therapies	Other
mTOR_inhibitor_everolimus	Gene	Chemical
Analysis	Other
Analysis	Other
mTOR_inhibitor_everolimus	Gene	Chemical
Ongoing_research	Other
Ongoing_research	Other
majority	Other
therapies	Other
research	Other
research	Other
anti-estrogen_therapy	Other
data	Other
majority	Other
therapy	Other
patients	Species
agents	Other
management_challenges	Other
therapies	Other
PI3K/AKT/mTOR_pathway	Other
selective_estrogen_receptor_modulators	Chemical
therapies	Other
therapies	Other
mTOR_inhibitor_everolimus	Gene	Chemical
Ongoing_research	Other
data	Other
supportive_care	Other
mTOR_inhibitor_everolimus	Gene	Chemical
mTOR_inhibitor_everolimus	Gene	Chemical
therapy	Other
data	Other
therapies	Other
patients	Species
therapies	Other
mTOR_inhibitor_everolimus	Gene	Chemical
therapy	Other
PI3K/AKT/mTOR_pathway	Other
therapy	Other
deaths	Other
research	Other
therapies	Other
mTOR_inhibitor_everolimus	Gene	Chemical
research	Other
therapies	Other
treatment	Other
Sexual_function	Other
problems	Other
participants	Species
Sexual_function	Other
dysfunctions	Other
main_problems	Other
participants	Species
average_time	Other
primary_sexual_dysfunctions	Other
instruments	Other
study	Other
main_problems	Other
changes	Other
circumstances	Other
514_women	Species
main_problems	Other
study	Other
events	Other
ERÎ±_polyubiquitination_selective_estrogen_receptor_degraders	Chemical
regulator	Other
transcriptional_regulator	Other
transcriptional_regulator	Other
posttranslational_modifications_interactions	Other
related	Other
extranuclear_activity	Other
may_key_factor	Other
regulator	Other
activity	Other
polyubiquitination	Other
related	Other
transcriptional_regulator	Other
related	Other
ERÎ±_polyubiquitination_estrogen_receptor_degraders	Chemical
polyubiquitination	Other
increase	Other
transcriptional_regulator	Other
regulator	Other
related	Other
regulator	Other
ERÎ±_polyubiquitination_estrogen_receptor_degraders	Chemical
regulator	Other
ERÎ±_polyubiquitination	Other
transcriptional_regulator	Other
extranuclear_activity	Other
ERÎ±_polyubiquitination_selective_estrogen_receptor_degraders	Chemical
transcriptional_regulator	Other
specific_protein_complexes	Other
aim	Other
Its_potential_practical_applications	Other
aim	Other
patients	Species
Its_potential_practical_applications	Other
patients	Species
One_photograph	Other
patients	Species
Its_potential_applications	Other
Its_potential_practical_applications	Other
One_photograph	Other
Their_treatment-related_cosmetic_changes	Other
patients	Species
patients	Species
Its_potential_applications	Other
patients	Species
One_photograph	Other
patients	Species
changes	Other
Its_potential_applications	Other
Agreement	Other
patients	Species
One_photograph	Other
correlation_coefficient	Other
intraclass_correlation_coefficient	Other
Its_potential_practical_applications	Other
patients	Species
partial_breast_irradiation	Other
accelerated_partial_breast_irradiation	Other
further_investigation	Other
S961	Chemical
IR_antagonist_S961	Chemical
effect	Other
IR_mRNA_expression_levels	Other
expression	Other
expression	Other
study	Other
S961	Chemical
study	Other
study	Other
IR_mRNA_expression_levels	Other
S961	Chemical
study	Other
study	Other
study	Other
breast_cancer_cells	Disease
mRNA_expression	Other
upregulated_expression	Other
breast_cancer_cells	Disease
S961	Chemical
study	Other
IR_mRNA_expression_levels	Other
aspects	Other
expression	Other
study	Other
several_aspects	Other
several_aspects	Other
S961	Chemical
breast_cancer_cells	Disease
expression	Other
breast_cancer_cells	Disease
mRNA_expression	Other
IR_mRNA_expression_levels	Other
expression	Other
proliferation	Other
aspects	Other
breast_cancer_cells	Disease
IR_mRNA_expression_levels	Other
IR_antagonist_S961	Chemical
S961	Chemical
S961	Chemical
expression	Other
study	Other
upregulated_expression	Other
breast_cancer_cells	Disease
expression	Other
study	Other
IR_mRNA_expression_levels	Other
S961	Chemical
expression	Other
IR_signalling	Other
IR_mRNA_expression_levels	Other
breast_cancer_cells	Disease
Immediate_Verbal_Memory_Index	Other
breast_radiotherapy	Other
mechanisms	Other
association	Other
mechanisms	Other
changes	Other
changes	Other
Memory_decline	Other
mechanisms	Other
adjuvant_breast_radiotherapy	Other
The_Delayed	Other
The_Delayed	Other
breast_radiotherapy	Other
Immediate_Verbal_Memory_Index	Other
three_visual_representations	Other
TAMs/CXCL1	Other
epithelial-mesenchymal_transition	Other
CXCL1_silencing	Gene
therapeutic_targets	Other
significant_reduction	Other
therapeutic_targets	Other
QPCR_screening	Other
QPCR_screening	Other
QPCR_screening	Other
targets	Other
targets	Other
CXCL1_silencing	Gene
QPCR_screening	Other
therapeutic_targets	Other
high_CXCL1_expression	Gene
TAMs/CXCL1	Other
QPCR_screening	Other
targets	Other
QPCR_screening	Other
therapeutic_targets	Other
QPCR_screening	Other
targets	Other
targets	Other
CXCL1_silencing	Gene
targets	Other
targets	Other
CXCL1	Gene
therapeutic_targets	Other
targets	Other
CXCL1	Gene
therapeutic_targets	Other
QPCR_screening	Other
high_CXCL1_expression	Gene
therapeutic_targets	Other
targets	Other
CXCL1_silencing	Gene
targets	Other
CXCL1_expression	Gene
QPCR_screening	Other
CXCL1_expression	Gene
therapeutic_targets	Other
3_patients	Species
4_patients	Species
Level_1_group	Other
patients	Species
other_patients	Species
doses	Other
efficacy	Other
patients	Species
dose	Other
doses	Other
ERI	Other
combination_therapy	Other
dose	Other
Japanese_patients	Species
tolerability	Other
I_clinical_study	Other
patients	Species
type	Other
Breast_cancer	Disease
